液体活检及其联合影像学在良恶性肺结节诊断的研究进展
Liquid Biopsy and Its Combination with Imaging in the Diagnostic Progress of Benign and Malignant Pulmonary Nodules
DOI: 10.12677/acm.2025.151257, PDF,   
作者: 阚 杰, 牟 康, 李小松*：重庆医科大学附属第一医院临床分子医学检测中心，重庆
关键词: 肺结节；液体活检；影像学；诊断；Pulmonary Nodules； Liquid Biopsy； Imaging； Diagnosis
摘要: 肺结节是早期肺癌的一种表现，检出率逐年增高，早期诊断依赖于多种影像学，由于假阳性率高而无法精准评估，存在过度诊断。液体活检通过非侵入式方法对外周血中循环肿瘤细胞、DNA甲基化及非编码RNA进行检测，具有较高灵敏度和特异性，逐渐成为肿瘤精准医疗领域强有力的诊断依据。本文就液体活检及其联合临床影像学在良恶性肺结节诊断中的研究进展进行综述。
Abstract: Pulmonary nodules are a manifestation of early-stage lung cancer, with detection rates increasing year by year. Early diagnosis relies on various imaging techniques, but the high rate of false positives makes it difficult to assess accurately, leading to overdiagnosis. Liquid biopsy, a non-invasive method, detects circulating tumor cells, DNA methylation, and non-coding RNA in peripheral blood with high sensitivity and specificity, gradually becoming a powerful diagnostic basis in the field of precision oncology. This article reviews the research progress of liquid biopsy and its combination with clinical imaging in the diagnosis of benign and malignant pulmonary nodules.
文章引用：阚杰, 牟康, 李小松. 液体活检及其联合影像学在良恶性肺结节诊断的研究进展[J]. 临床医学进展, 2025, 15(1): 1925-1931. https://doi.org/10.12677/acm.2025.151257

参考文献

[1] Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., et al. (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 74, 229-263. [Google Scholar] [CrossRef] [PubMed]
[2] Lin, Y., Leng, Q., Jiang, Z., Guarnera, M.A., Zhou, Y., Chen, X., et al. (2017) A Classifier Integrating Plasma Biomarkers and Radiological Characteristics for Distinguishing Malignant from Benign Pulmonary Nodules. International Journal of Cancer, 141, 1240-1248. [Google Scholar] [CrossRef] [PubMed]
[3] 孙硕, 王锋, 何立, 杨文文, 韩彪, 赵蒙蒙, 陈昶, 马敏杰. 液体活检生物标志物及其联合影像学在肺癌早期诊断中应用的研究进展[J]. 中国胸心血管外科临床杂志, 2023, 30(2): 313-319.
[4] 中华医学会检验医学分会分子诊断学组. 循环肿瘤细胞临床应用与实验室检测专家共识[J]. 中华检验医学杂志, 2021, 44(11): 1008-1020.
[5] 李凯迪, 梁乃新, 刘洪生, 李力, 黄诚, 秦应之, 韩志军, 邴钟兴, 刘磊, 徐源, 徐慧慧, 杨延莲, 彭佳茜, 霍力, 李方, 胡志远, 李单青. 基于多肽的循环肿瘤细胞纳米磁珠检测对肺部结节的鉴别诊断价值[J]. 中国胸心血管外科临床杂志, 2018, 25(7): 560-566.
[6] Liu, B., Huang, L., Cao, Y., Tan, Q.L., Wang, Y.L. and Guo, Q.N. (2020) Application of Folate Receptor-Positive Circulating Tumor Cells in Auxiliary Diagnosis of Malignant Pulmonary Nodules. Journal of Third Military Medical University, 43, 2330-2335.
[7] Zhong, M., Zhang, Y., Pan, Z., Wang, W., Zhang, Y., Weng, Y., et al. (2021) Clinical Utility of Circulating Tumor Cells in the Early Detection of Lung Cancer in Patients with a Solitary Pulmonary Nodule. Technology in Cancer Research & Treatment, 20. [Google Scholar] [CrossRef] [PubMed]
[8] Duan, X., Liu, Z. and Xu, S. (2017) Research Progresses of Circulating Tumor Cells in Diagnosis and Treatment of Early Lung Cancer. Chinese Journal of Lung Cancer, 20, 703-709. (In Chinese)
[9] 尤培林, 丁运, 郭天兴, 等. 循环肿瘤细胞联合低剂量螺旋CT对恶性孤立性肺结节病理浸润的预测价值[J]. 中华实验外科杂志, 2021, 38(2): 360-363.
[10] Duan, G., Zhang, X., Wang, H., Wang, Z., Zhang, H., Yu, L., et al. (2020) Circulating Tumor Cells as a Screening and Diagnostic Marker for Early-Stage Non-Small Cell Lung Cancer. OncoTargets and Therapy, 13, 1931-1939. [Google Scholar] [CrossRef] [PubMed]
[11] Kang, B.J., Ra, S.W., Lee, K., Lim, S., Son, S.H., Ahn, J., et al. (2020) Circulating Tumor Cell Number Is Associated with Primary Tumor Volume in Patients with Lung Adenocarcinoma. Tuberculosis and Respiratory Diseases, 83, 61-70. [Google Scholar] [CrossRef] [PubMed]
[12] Yao, H., Wang, Z., Yang, J., Xu, X. and Song, Y. (2021) Simultaneous in Situ Detection of Protein Expression of Multiple Tumor Markers of Circulating Tumor Cells and Heteroploid of Chromosome 8 in Primary Lung Cancer. Annals of Translational Medicine, 9, 1772-1772. [Google Scholar] [CrossRef] [PubMed]
[13] Ulivi, P. and Silvestrini, R. (2013) Role of Quantitative and Qualitative Characteristics of Free Circulating DNA in the Management of Patients with Non-Small Cell Lung Cancer. Cellular Oncology, 36, 439-448. [Google Scholar] [CrossRef] [PubMed]
[14] Khatami, F. and Tavangar, S.M. (2018) Circulating Tumor DNA (ctDNA) in the Era of Personalized Cancer Therapy. Journal of Diabetes & Metabolic Disorders, 17, 19-30. [Google Scholar] [CrossRef] [PubMed]
[15] Zhang, L., Liang, Y., Li, S., Zeng, F., Meng, Y., Chen, Z., et al. (2019) The Interplay of Circulating Tumor DNA and Chromatin Modification, Therapeutic Resistance, and Metastasis. Molecular Cancer, 18, Article No. 36. [Google Scholar] [CrossRef] [PubMed]
[16] Iwahashi, N., Sakai, K., Noguchi, T., Yahata, T., Toujima, S., Nishio, K. and Ino, K. (2018) A Comprehensive Gene Mutation Analysis of Liquid Biopsy Samples from Patients with Metastatic Colorectal Cancer to the Ovary: A Case Report. Oncology Letters, 16, 6431-6436.
[17] Hofman, P. (2020) Liquid Biopsy for Lung Cancer Screening: Usefulness of Circulating Tumor Cells and Other Circulating Blood Biomarkers. Cancer Cytopathology, 129, 341-346. [Google Scholar] [CrossRef] [PubMed]
[18] Gassa, A., Fassunke, J., Schueten, S., Kuhlmann, L., Scherer, M., Qien, J., et al. (2021) Detection of Circulating Tumor DNA by Digital Droplet PCR in Resectable Lung Cancer as a Predictive Tool for Recurrence. Lung Cancer, 151, 91-96. [Google Scholar] [CrossRef] [PubMed]
[19] Soria-Comes, T., Palomar-Abril, V., Ureste, M.M., Guerola, M.T. and Maiques, I.C.M. (2019) Real-World Data of the Correlation between EGFR Determination by Liquid Biopsy in Non-Squamous Non-Small Cell Lung Cancer (NSCLC) and the EGFR Profile in Tumor Biopsy. Pathology & Oncology Research, 26, 845-851. [Google Scholar] [CrossRef] [PubMed]
[20] Campos-Carrillo, A., Weitzel, J.N., Sahoo, P., Rockne, R., Mokhnatkin, J.V., Murtaza, M., et al. (2020) Circulating Tumor DNA as an Early Cancer Detection Tool. Pharmacology & Therapeutics, 207, Article ID: 107458. [Google Scholar] [CrossRef] [PubMed]
[21] Yu, H., Wang, Y., Yu, Q., Zhang, H., Ma, W., Shang, S. and Wang, D. (2015) Significance of Plasma Hepatocyte Growth Factor in Diagnosis of Benign and Malignant Solitary Pulmonary Nodules. International Journal of Clinical and Experimental Pathology, 8, 2063-2067.
[22] Liu, D., Mao, Y. and Ma, H. (2021) Value of Circulating Tumor Cells in the Diagnosis and Treatment of Solitary Pulmonary Nodules. Annals of Translational Medicine, 9, 501-501. [Google Scholar] [CrossRef] [PubMed]
[23] Xu, S., Luo, J., Tang, W., Bao, H., Wang, J., Chang, S., et al. (2024) Detecting Pulmonary Malignancy against Benign Nodules Using Noninvasive Cell-Free DNA Fragmentomics Assay. ESMO Open, 9, Article ID: 103595. [Google Scholar] [CrossRef] [PubMed]
[24] Jiang, W., Phillips, S.A., Newbury, R.O., Naheedy, J.H. and Newfield, R.S. (2021) Diagnostic Utility of Fine Needle Aspiration Cytology in Pediatric Thyroid Nodules Based on Bethesda Classification. Journal of Pediatric Endocrinology and Metabolism, 34, 449-455. [Google Scholar] [CrossRef] [PubMed]
[25] Jee, Y.H., Celi, F.S., Sampson, M., Sacks, D.B., Remaley, A.T., Kebebew, E., et al. (2015) Midkine Concentrations in Fine‐Needle Aspiration of Benign and Malignant Thyroid Nodules. Clinical Endocrinology, 83, 977-984. [Google Scholar] [CrossRef] [PubMed]
[26] Li, J., Xia, T., Yang, X., Dong, X., Liang, J., Zhong, N., et al. (2018) Malignant Solitary Pulmonary Nodules: Assessment of Mass Growth Rate and Doubling Time at Follow-Up CT. Journal of Thoracic Disease, 10, S797-S806. [Google Scholar] [CrossRef] [PubMed]
[27] Zhang, M. and Lin, O. (2016) Molecular Testing of Thyroid Nodules: A Review of Current Available Tests for Fine-Needle Aspiration Specimens. Archives of Pathology & Laboratory Medicine, 140, 1338-1344. [Google Scholar] [CrossRef] [PubMed]
[28] Zhou, Y., Gong, G., Wang, H., Habibabady, Z.A., Lang, P., Hales, R., et al. (2019) Transthoracic Fine-Needle Aspiration Diagnosis of Solid, Subsolid, and Partially Calcified Lung Nodules: A Retrospective Study from a Single Academic Center. CytoJournal, 16, 16. [Google Scholar] [CrossRef] [PubMed]
[29] Liang, W., Chen, Z., Li, C., Liu, J., Tao, J., Liu, X., et al. (2021) Accurate Diagnosis of Pulmonary Nodules Using a Noninvasive DNA Methylation Test. Journal of Clinical Investigation, 131, e145973. [Google Scholar] [CrossRef] [PubMed]
[30] Yang, M., Yu, H., Feng, H., Duan, J., Wang, K., Tong, B., et al. (2024) Enhancing the Differential Diagnosis of Small Pulmonary Nodules: A Comprehensive Model Integrating Plasma Methylation, Protein Biomarkers, and LDCT Imaging Features. Journal of Translational Medicine, 22, Article No. 984. [Google Scholar] [CrossRef] [PubMed]
[31] Song, C., Sun, Y., Chen, Y., Shen, Y., Lei, H., Mao, W., et al. (2024) Differential Diagnosis of Pulmonary Nodules and Prediction of Invasive Adenocarcinoma Using Extracellular Vesicle DNA. Clinical and Translational Medicine, 14, e1582. [Google Scholar] [CrossRef] [PubMed]
[32] Li, J., Sina, A.A.I., Antaw, F., Fielding, D., Möller, A., Lobb, R., et al. (2022) Digital Decoding of Single Extracellular Vesicle Phenotype Differentiates Early Malignant and Benign Lung Lesions. Advanced Science, 10, e2204207. [Google Scholar] [CrossRef] [PubMed]
[33] 中华医学会呼吸病学分会, 中国肺癌防治联盟专家组. 肺结节诊治中国专家共识(2024年版) [J]. 中华结核和呼吸杂志, 2024, 47(8): 716-729.
[34] He, J., Wang, B., Tao, J., Liu, Q., Peng, M., Xiong, S., et al. (2023) Accurate Classification of Pulmonary Nodules by a Combined Model of Clinical, Imaging, and Cell-Free DNA Methylation Biomarkers: A Model Development and External Validation Study. The Lancet Digital Health, 5, e647-e656. [Google Scholar] [CrossRef] [PubMed]
[35] Song, Z. and Liu, Y. (2018) Progress of Liquid Biopsy in Early Diagnosis of Lung Cancer. Chinese Journal of Lung Cancer, 21, 620-627. (In Chinese)

为你推荐